google_counter
background_img

Lutetium-177 PSMA Therapy

Due to the difficulties associated with the organization of treatment in Turkey, Switzerland, South Korea and India, we are not currently processing requests to these regions.

If you are interested in treatment in Germany, please leave a request and our specialists will contact you as soon as possible.

 

Cost for treatment

Diagnosis of the prostate cancer with PSMA-PET
3404.6
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
18044.25
Prostate Cancer Treatment with Lutetium-177 PSMA
8536

Helios Hospital Berlin-Buch

9.7/10
location_onGermany, Berlin

Department of Nuclear Medicine

According to the reputable Focus magazine, the Helios Hospital Berlin-Buch ranks among the top medical facilities in Germany! The clinic is proud of its rich history, which dates back over 100 years, as well as the status of a maximum care medical center with exceptionally high success treatment rates. The medical institution is
Diagnosis of the prostate cancer with PSMA-PET
6258.65
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
19385.5
Prostate Cancer Treatment with Lutetium-177 PSMA
26457.45 help25607.45

University Hospital Frankfurt am Main

10/10
location_onGermany, Frankfurt am Main

Department of Nuclear Medicine

According to the reputable Focus magazine, the University Hospital Frankfurt am Main ranks among the top German medical facilities! The hospital was founded in 1914 and today is a well-known German medical facility, which combines rich traditions and scientific innovations. A medical team of more than 6,500 employees cares about
Diagnosis of the prostate cancer with PSMA-PET
6180.35
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
19839.35
Prostate Cancer Treatment with Lutetium-177 PSMA
30710

University Hospital Carl Gustav Carus Dresden

9.1/10
location_onGermany, Dresden

Department of Nuclear Medicine

According to the reputable Focus magazine, the University Hospital Carl Gustav Carus Dresden ranks among the top five German hospitals! The hospital is the benchmark for modern high-quality medicine. Positioning itself as a maximum care medical facility, the hospital represents all medical fields. There are 26 specialized depart
Diagnosis of the prostate cancer with PSMA-PET
8084.2
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
25819.15
Prostate Cancer Treatment with Lutetium-177 PSMA
19432

University Hospital Erlangen

9.1/10
location_onGermany, Erlangen

Department of Nuclear Medicine

According to the Focus magazine, University Hospital Erlangen ranks among the best medical facilities in Germany! The hospital is one of the leading healthcare facilities in Bavaria and offers top-class medical care distinguished by the close intertwining of clinical activities with research and training of medical students. The
Diagnosis of the prostate cancer with PSMA-PET
6719.75
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
20941.35
Prostate Cancer Treatment with Lutetium-177 PSMA
23181.6

University Hospital Bonn

9.2/10
location_onGermany, Bonn

Department of Nuclear Medicine

According to the authoritative Focus magazine, the University Hospital Bonn ranks among the top ten medical facilities in Germany! The hospital was opened on January 1, 2001, although in fact it inherits the medical facility, which operated at the Faculty of Medicine of the University of Bonn. The hospital in Germany combin
Diagnosis of the prostate cancer with PSMA-PET
6812.55
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
22315.95
Prostate Cancer Treatment with Lutetium-177 PSMA
26212.1

University Hospital Duesseldorf

9.5/10
location_onGermany, Duesseldorf

Department of Nuclear Medicine

According to the authoritative Focus magazine, the University Hospital Duesseldorf ranks among the top Germany hospitals! The hospital is an excellent example of a combination of high-quality health care, research and teaching activities. With more than 50,000 inpatients and about 300,000 outpatients every year, the hospital is
Diagnosis of the prostate cancer with PSMA-PET
6902.45
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
21746.1
Prostate Cancer Treatment with Lutetium-177 PSMA
25988.8

University Hospital of Ludwig Maximilian University of Munich

10/10
location_onGermany, Munich

Department of Nuclear Medicine

According to the Focus magazine, the University Hospital of Ludwig Maximilian University of Munich is regularly ranked among the best medical institutions in Germany! The hospital is the largest multidisciplinary medical facility, as well as a leading research and training center in Germany and Europe. The hospital is proud of i
Diagnosis of the prostate cancer with PSMA-PET
6916.95
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
22062.2
Prostate Cancer Treatment with Lutetium-177 PSMA
28417.25 help27817.25

University Hospital Halle (Saale)

9.6/10
location_onGermany, Halle

Department of Nuclear Medicine

According to the prestigious Focus magazine, the University Hospital Halle (Saale) ranks among the top German medical facilities! The history of the hospital has more than 300 years, and during this time it managed to earn an excellent reputation not only in Germany, but throughout the world. The hospital positions itself as a s
Diagnosis of the prostate cancer with PSMA-PET
6207.9
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
19086.8
Prostate Cancer Treatment with Lutetium-177 PSMA
26299.1

University Hospital Jena

8.9/10
location_onGermany, Jena

Department of Nuclear Medicine

According to the prestigious Focus magazine, the University Hospital Jena regularly ranks among the top German medical facilities! The hospital has positioned itself as a multidisciplinary medical facility with a long history of more than 200 years. Since its foundation, the hospital has been constantly developing and modernizin
Diagnosis of the prostate cancer with PSMA-PET
7048.9
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
21856.3
Prostate Cancer Treatment with Lutetium-177 PSMA
26103.35

University Hospital Rechts der Isar Munich

9.8/10
location_onGermany, Munich

Department of Nuclear Medicine

The University Hospital Rechts der Isar Munich was founded in 1834. It combines long traditions with the very latest advances in modern medicine. The medical facility includes 33 specialized departments and 20 interdisciplinary centers, where patients can receive top-class medical care in all medical fields. The hospital annuall
Diagnosis of the prostate cancer with PSMA-PET
5416.2
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
22108.6
Prostate Cancer Treatment with Lutetium-177 PSMA
27469.25

University Hospital Würzburg

9.2/10
location_onGermany, Würzburg

Department of Nuclear Medicine

According to the Focus magazine in 2019, the University Hospital Würzburg ranks among the top national German hospitals! The hospital is one of the oldest medical facilities in Germany. The centuries-old traditions of first-class treatment are combined with the very latest achievements of modern evidence-based medicine and
Diagnosis of the prostate cancer with PSMA-PET
6173.1
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
19373.9
Prostate Cancer Treatment with Lutetium-177 PSMA
27102.4

University Hospital Muenster

9.8/10
location_onGermany, Muenster

Department of Adult and Pediatric Nuclear Medicine

According to the Focus magazine, the University Hospital Muenster ranks among the top German hospitals! The hospital belongs to the most prestigious medical institutions in Germany. The hospital is distinguished by a high professionalism of its doctors, state-of-the-art technological equipment and the availability of the most ad
Diagnosis of the prostate cancer with PSMA-PET
6251.4
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
19701.6
Prostate Cancer Treatment with Lutetium-177 PSMA
26045.35

University Hospital Tuebingen

8.7/10
location_onGermany, Tuebingen

Department of Nuclear Medicine and Clinical Imaging Diagnostics

According to the prestigious medical publication Focus, the University Hospital Tuebingen ranks among the top five German hospitals! The hospital was founded in 1805, therefore it is proud of its long history, unique experience, and outstanding achievements in the field of medical care, as well as research and teaching activitie
Diagnosis of the prostate cancer with PSMA-PET
6577.65
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
20565.8
Prostate Cancer Treatment with Lutetium-177 PSMA
26223.7

University Hospital Heidelberg

9.8/10
location_onGermany, Heidelberg

Department of Nuclear Medicine

According to Focus magazine, the University Hospital Heidelberg ranks among the top five hospitals in Germany! The hospital is one of the most advanced and reputable medical institutions not only in Germany, but throughout Europe. There are more than 43 specialized departments and 13 medical institutes, which cover all fields of
Diagnosis of the prostate cancer with PSMA-PET
0
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
0
Prostate Cancer Treatment with Lutetium-177 PSMA
0

University Hospital Essen

9.6/10
location_onGermany, Essen

Department of Nuclear Medicine

According to the authoritative Focus magazine the University Hospital Essen ranks among the top German hospitals! With 27 specialized departments and 24 institutes, the hospital in Germany is a maximum care medical facility. The hospital has 1,300 beds for inpatient treatment. A highly qualified medical team of more than 6,000 e
Diagnosis of the prostate cancer with PSMA-PET
6354.35
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
19413.05
Prostate Cancer Treatment with Lutetium-177 PSMA
26286.05

University Hospital Saarland Homburg

9.8/10
location_onGermany, Homburg

Department of Nuclear Medicine

The University Hospital Saarland is the largest hospital in the city of Homburg and the most important medical facility in the region. The hospital, which currently has 30 specialized departments and 20 institutes, was founded in 1947 and operates on the basis of the Saarland University. The hospital plays a leading role in medi
Diagnosis of the prostate cancer with PSMA-PET
7338.4 help6338.4
Neuroendocrine Tumors (NETs) Treatment with Lutetium-177-DOTATATE
18050.05
Prostate Cancer Treatment with Lutetium-177 PSMA
27520
| from Booking Health GmbH

Cancer treatment with Lutetium-177 includes administration of the therapeutic radionuclide Lu-177 that accumulates targetedly in all cancer foci and irradiates them.

Lutetium-177 PSMA therapy is indicated for patients with advanced prostate cancer who have not responded to the conventional treatment protocol.

The price of Lutetium therapy starts from 16,381 €.

The best hospitals are Helios Hospital Berlin-Buch, University Hospital of Ludwig Maximilian University of Munich, University Hospital Frankfurt-am-Main.

 

In terms of clinical course, prostate cancer is a relatively favorable condition. It can be treated even at the advanced stages. However, sooner or later the disease reaches that stage when chemotherapy is ineffective and various organs are affected by metastases. In such clinical situations, Lutetium-177 PSMA radionuclide therapy comes to the rescue. Being connected to the specific molecular carrier, Lutetium-177 reliably binds to malignant cells regardless of their localization. Local irradiation destroys metastatic foci and helps control the disease progression. Due to the unique mechanism of action, PSMA therapy with Lutetium-177 is effective in men who no longer respond to chemotherapy or hormonal therapy. During the last decades the procedure has become the therapy of choice in such patients regardless of their age.

Content

  1. What is Lutetium therapy?
  2. Who is eligible for 177 Lutetium therapy?
  3. How does Lutetium 177 PSMA therapy work?
  4. Health effects of lutetium 177 PSMA therapy
  5. What is the cost of Lutetium treatment in European hospitals?

What is Lutetium therapy?

 

The treatment involves the use of Lutetium-177 (Lu 177) labeled prostate-specific membrane antigen, hence the name, PSMA therapy.

Radionuclide substance gives off radiation, but it is very short – only a few millimeters.  This substance should destroy not only the primary tumor, but also metastatic foci of prostate cancer.

A radiopharmaceutical is administered to the patient intravenously. It accumulates only in tumor cells, while the healthy ones get just a minimal amount, so they are almost not damaged. With its action, 177 Lutetium therapy destroys cancer cells. As a result, the size of the primary tumor lesion is significantly reduced and most metastases disappear.

Who is eligible for 177 Lutetium therapy?

 

PSMA Lutetium-177 therapy is the targeted treatment that is used in the combination therapeutic schemes for advanced prostate cancer. It is prescribed in the presence of multiple distant metastases. Indeed, the main advantage of the method is that it is not necessary to know the exact location of prostate cancer foci. It is impossible to detect them all and remove, but systemic therapies can affect cancer cells, regardless of their location.

PSMA therapy is an alternative to chemotherapy. It is prescribed in the following situations:

  • Chemotherapy does not yield any result – the tumor does not respond to drug administration and continues to grow in size
  • Cytostatics are contraindicated for the patient for health reasons – he may not tolerate another course
  • The patient himself refuses to undergo chemotherapy because he no longer wants to endure side effects

Other field of Lu-177 application is treatment of the neuroendocrine tumors, particularly, gastro-, entero- and pancreatic ones (GEP tumors). GEP tumors have specific receptors for the somatostatin (somatostatin receptors, SSTR) on their cells membrane. Thus, during the Lutetium therapy for neuroendocrine carcinoma specific peptides that resemble somatostatin’s structure are labeled with Lutetium compounds (typically these are Lu dotatate and octreotate).

Due to the affinity between SSTR and Lu-labeled compounds, Lutetium dotatate treatment acts on the GEP tumors selectively. It decreases radiation burden on the healthy tissues. In addition, Lutetium dotatate therapy can be performed in patients with slightly impaired kidney function. Lutetium 177 octreotate therapy is another type of peptide receptor radionuclide therapy (PRRT).

How does Lutetium-177 PSMA therapy work?

 

Before the procedure the patient visits the doctor for clinical examination and review of the existing medical reports (e.g. PSMA PET CT). Blood tests are carried out, so the doctor can be sure that the patient's liver and kidney functions are normal.

After this, the radiopharmaceutical is injected into the patient's vein slowly using a syringe. This is the whole procedure, actually. Additional drugs may be used to reduce the risk of complications and reduce side effects. The external cooling of the salivary glands with ice packs is carried out in order to prevent suppression of their work and xerostomia (dry mouth).

During the course of treatment, the man stays in a screened ward, as he is a source of beta-radiation for a while. Urine and stool become radioactive, so it is recommended to drink a lot of water and urinate frequently, flush the toilet 2-3 extra times, and wash the underclothes separately for up to 7 days. The patient is allowed to take personal belongings to the ward. They will not become radioactive and can be used in the future.

A day after the introduction of Lutetium-177 the patient will undergo the control scintigraphy. This is a follow-up examination, which allows for the evaluation of the treatment results. 10 days later, the person will come to the clinic again and undergo a repeated study. The scintigraphy demonstrates the number of bone metastases and their size.

Several sessions of Lutetium-177 treatment are usually carried out in order to achieve the long-lasting result. On average, the patient undergoes three treatment cycles. The recommended intervals between them are 8 weeks. Medical monitoring is provided through PET-CT, PSA blood test, and general clinical studies. The doctors also control liver, kidney, and bone marrow function.

Health effects of Lutetium-177 PSMA therapy

 

Lutetium 177 for cancer treatment is a relatively safe method. It does not cause irreversible complications. The doctors carefully monitor the condition of the patient and those for whom therapy can be harmful are not allowed to undergo it.  If prostate cancer is treated using this therapy, the doctors carefully monitor that the damage to healthy tissues was minimal. To this end, the following measures are taken:

  • Patient examination prior to treatment to identify possible contraindications
  • Cooling of the salivary glands in the course of therapy in order to prevent accumulation of the radiopharmaceutical in them
  • In case of liver metastases, the patient may need bile duct stenting in order to prevent the development of obstructive jaundice due to edema and impaired bile outflow into the duodenum
  • Intravenous infusion of crystalloid solutions serves to protect kidneys
  • In case of side effects, there are used drugs to relieve them

Long term benefit of Lutetium-177 on prostate cancer is still under the investigation, but the current results are very promising. Treatment of the disease with Lutetium can cause side effects. The most frequent of them are nausea, swelling of the oral mucosa, impaired swallowing and difficulty speaking. All these side effects are temporary.

The complications may include liver, kidney dysfunction, as well as inhibition of the hematopoietic function of the red bone marrow. In order to timely identify the emerging complications, the patient is constantly undergoing clinical and biochemical blood tests. These tests are conducted before starting prostate cancer treatment, as well as after each session.

What is the cost of Lutetium treatment in European hospitals?

 

The prostate cancer treatment with Lutetium is provided in the best clinics abroad. Many patients go to Germany to get highly qualified and high-tech medical care for malignant tumors. Booking Health can arrange this for you. Our services and benefits:

  • Organization of Lutetium 177 therapy in one of the best clinics abroad
  • Affordable treatment cost, which will be up to 50% lower due to the lack of extra charges for foreign patients
  • Communication with the doctors of the clinic and its administration both prior to prostate cancer treatment and after its completion
  • Preparation of the program without previous examinations
  • Appointment at the dates convenient for the patient
  • Assistance in purchasing and transmission of medicines
  • Control of invoices, treatment costs, return of unspent funds
  • Organization of either additional examination or treatment of diseases in the clinic

Booking Health will provide high quality services. Our employees will book airline tickets for you, choose the hotel closest to the medical facility, meet you at the airport and take you to the clinic by car.

 

Authors: 

The article was edited by medical experts, board certified doctors Dr. Nadezhda Ivanisova and Dr. Sergey Pashchenko. For the treatment of the conditions referred to in the article, you must consult a doctor; the information in the article is not intended for self-medication!

 

Sources:

National Center for Biotechnology

Cancer Research Institute

Cancer Support Community




Feedback of our customers from other resources

Need Help?

Thank you!

We received your treatment application in the best Europe clinics. Our manager will contact you within the next 24 hours.